KN5-26634-52211 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-26
Dose 1 — Pfizer-BioNTech
2021-02-10
Registered in v-safe
2021-02-10
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-15
Dose 2 — Pfizer-BioNTech
2021-02-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-02-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-20
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-22
Health check-in — day 7, dose 2
Feeling: Good · Headache, Diarrhea

Adult check-in
2021-03-01
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-09
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-15
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-22
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-29
Survey response — day 42, dose 2
MedDRA: Vertigo — Feeling: Fair · Be unable to do your normal daily activities

Free text: Vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-18
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-16
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-29
Dose 3 — Pfizer-BioNTech
2022-02-15
Survey response — 12 months, dose 2
MedDRA: Influenza, Nasopharyngitis, Premature delivery — Feeling: Good · Be unable to do your normal daily activities

Free text: Cold/Flu symptons and gave birth to a baby boy prematurely at 34 weeks

MedDRA releases: 2024-11 · check-in free text available
2022-05-30
Survey response — 6 months, dose 3
MedDRA: Nasopharyngitis — Feeling: Fair

Free text: More susceptible to colds

MedDRA releases: 2024-11 · check-in free text available
2022-11-29
Survey response — 12 months, dose 3
MedDRA: Dizziness — Feeling: Good

Free text: Dizziness and lightheadedness sporadically with no onset of illness

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-26	Pfizer-BioNTech
2	2021-02-15	Pfizer-BioNTech
3	2021-11-29	Pfizer-BioNTech	No

Free text

Release 6 — day 42, dose 2

2021-03-29

Symptoms: Vertigo

Release 11 — 12 months, dose 2

2022-02-15

Symptoms: Cold/Flu symptons and gave birth to a baby boy prematurely at 34 weeks

Release 11 — 6 months, dose 3

2022-05-30

Symptoms: More susceptible to colds

Release 12 — 12 months, dose 3

2022-11-29

Symptoms: Dizziness and lightheadedness sporadically with no onset of illness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dizziness	·	·	✓
SD	Influenza	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Premature delivery	·	·	✓
SD	Vertigo	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release